MOEXIPRIL HYDROCHLORIDE

MOEXIPRIL HYDROCHLORIDE was reported 67 times

MOEXIPRIL HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 POIKILODERMA 2 0.0185
1 URINE SODIUM DECREASED 2 0.0154
2 SCAN MYOCARDIAL PERFUSION ABNORMAL 1 0.0065
3 BLOOD CREATINE PHOSPHOKINASE DECREASED 2 0.0061
4 CARDIOACTIVE DRUG LEVEL DECREASED 1 0.0058
5 FIBROUS HISTIOCYTOMA 2 0.0057
6 RETINAL ANEURYSM 1 0.0050
7 LENTIGO 2 0.0040
8 CATHETERISATION CARDIAC ABNORMAL 1 0.0037
9 ELECTROCARDIOGRAM QRS COMPLEX SHORTENED 1 0.0026
10 CAROTID BRUIT 1 0.0026
11 INJECTION SITE BURNING 1 0.0013
12 BLOOD SODIUM ABNORMAL 1 0.0009
13 ECHOCARDIOGRAM ABNORMAL 1 0.0007
14 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 1 0.0007
15 ANGIOPLASTY 1 0.0007
16 URINE ANALYSIS ABNORMAL 2 0.0007
17 BLADDER PAIN 2 0.0006
18 NIGHT BLINDNESS 1 0.0006
19 CYSTOID MACULAR OEDEMA 1 0.0005
20 MOTION SICKNESS 1 0.0005
21 PYELONEPHRITIS ACUTE 1 0.0005
22 CREATININE RENAL CLEARANCE DECREASED 2 0.0005
23 EYELID PAIN 1 0.0005
24 MELANOCYTIC NAEVUS 2 0.0005
25 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
26 LACUNAR INFARCTION 1 0.0004
27 EYELID IRRITATION 1 0.0004
28 INCREASED BRONCHIAL SECRETION 1 0.0004
29 PERIPHERAL VASCULAR DISORDER 2 0.0004
30 CEREBROVASCULAR DISORDER 1 0.0003
31 CHEST X-RAY ABNORMAL 1 0.0003
32 SUPRAVENTRICULAR EXTRASYSTOLES 1 0.0003
33 DIFFICULTY IN WALKING 1 0.0003
34 CAROTID ARTERY STENOSIS 1 0.0003
35 FACIAL PARESIS 1 0.0003
36 MACULOPATHY 1 0.0003
37 NEURODERMATITIS 1 0.0003
38 OESOPHAGEAL DISORDER 1 0.0003
39 ORAL INFECTION 1 0.0003
40 BLOOD ALBUMIN DECREASED 2 0.0003
41 LOW TURNOVER OSTEOPATHY 1 0.0003
42 CANDIDIASIS 1 0.0002
43 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 1 0.0002
44 LUNG NEOPLASM 1 0.0002
45 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
46 SPINAL OSTEOARTHRITIS 2 0.0002
47 CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0002
48 CORONARY ARTERIAL STENT INSERTION 1 0.0002
49 SLUGGISHNESS 2 0.0002
50 STRESS FRACTURE 1 0.0002
51 MACULAR OEDEMA 1 0.0002
52 HYPOVOLAEMIA 1 0.0002
53 TENSION 1 0.0002
54 SCOLIOSIS 1 0.0002
55 POOR QUALITY DRUG ADMINISTERED 1 0.0002
56 ECCHYMOSIS 1 0.0001
57 DIALYSIS 2 0.0001
58 RETINAL HAEMORRHAGE 1 0.0001
59 FEELING DRUNK 1 0.0001
60 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
61 STENT PLACEMENT 1 0.0001
62 BLOOD UREA INCREASED 2 0.0001
63 CARDIAC MURMUR 1 0.0001
64 PRODUCT PACKAGING ISSUE 1 0.0001
65 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
66 HYPERCHOLESTEROLAEMIA 1 0.0001
67 SINUS BRADYCARDIA 1 0.0001
68 KIDNEY INFECTION 2 0.0001
69 VENTRICULAR EXTRASYSTOLES 1 0.0001
70 MENSTRUATION DELAYED 1 0.0001
71 INJECTION SITE NODULE 1 0.0001
72 HYPERTENSIVE CRISIS 1 0.0001
73 MITRAL VALVE INCOMPETENCE 1 0.0001
74 PRODUCT AVAILABILITY ISSUE 2 0.0001
75 DERMATITIS CONTACT 1 0.0001
76 CHOLECYSTITIS 1 0.0001
77 CARDIOMEGALY 1 0.0001
78 INJECTION SITE DISCOLOURATION 1 0.0001
79 SINUS CONGESTION 1 0.0001
80 DRUG TOXICITY 1 0.0001
81 PROSTATIC SPECIFIC ANTIGEN INCREASED 1 0.0001
82 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
83 RENAL FAILURE ACUTE 3 0.0001
84 SINUS TACHYCARDIA 1 0.0001
85 CARDIOMYOPATHY 1 0.0001
86 CORONARY ARTERY DISEASE 2 0.0001
87 DRUG DISPENSING ERROR 1 0.0001
88 EJECTION FRACTION DECREASED 1 0.0001
89 ABSCESS 1 0.0001
90 BLOOD PRESSURE DECREASED 4 0.0001
91 HEMIPARESIS 1 0.0001
92 MULTI-ORGAN FAILURE 1 0.0001
93 DEVICE USE ISSUE 1 0.0001
94 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
95 ISCHAEMIC STROKE 1 0.0001
96 POST PROCEDURAL COMPLICATION 1 0.0001
97 LOWER LIMB FRACTURE 1 0.0001
98 PSORIATIC ARTHROPATHY 2 0.0000
99 PULMONARY HYPERTENSION 1 0.0000
100 INTENTIONAL DRUG MISUSE 1 0.0000
101 SNEEZING 1 0.0000
102 HEART RATE IRREGULAR 1 0.0000
103 LOCALISED INFECTION 1 0.0000
104 PRESYNCOPE 1 0.0000
105 OSTEONECROSIS OF JAW 1 0.0000
106 FLUSHING 4 0.0000
107 ANAPHYLACTIC SHOCK 1 0.0000
108 ANHEDONIA 1 0.0000
109 FEAR 1 0.0000
110 MOOD ALTERED 1 0.0000
111 RESPIRATORY DISTRESS 1 0.0000
112 MENTAL STATUS CHANGES 1 0.0000
113 ARTHROPATHY 2 0.0000
114 MEDICATION ERROR 2 0.0000
115 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
116 LETHARGY 2 0.0000
117 RENAL INJURY 1 0.0000
118 HEPATIC FAILURE 1 0.0000
119 APHASIA 1 0.0000
120 FEMUR FRACTURE 1 0.0000
121 HIP FRACTURE 1 0.0000
122 BLOOD CREATININE INCREASED 2 0.0000
123 CHOLELITHIASIS 1 0.0000
124 INFUSION RELATED REACTION 2 0.0000
125 VISUAL ACUITY REDUCED 1 0.0000
126 DEHYDRATION 4 0.0000
127 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
128 GASTRIC DISORDER 1 0.0000
129 NIGHTMARE 1 0.0000
130 NEOPLASM PROGRESSION 1 0.0000
131 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
132 OEDEMA PERIPHERAL 3 0.0000
133 OSTEOPOROSIS 1 0.0000
134 TREATMENT FAILURE 2 0.0000
135 POLLAKIURIA 1 0.0000
136 CEREBROVASCULAR ACCIDENT 4 0.0000
137 PULMONARY OEDEMA 1 0.0000
138 PRODUCT QUALITY ISSUE 3 0.0000
139 HYPOKALAEMIA 1 0.0000
140 BLOOD CHOLESTEROL INCREASED 1 0.0000
141 ASTHENIA 8 0.0000
142 RENAL CANCER 1 0.0000
143 DRY EYE 1 0.0000
144 CELLULITIS 1 0.0000
145 BLOOD PRESSURE INCREASED 3 0.0000
146 SINUSITIS 2 0.0000
147 HAEMOGLOBIN DECREASED 2 0.0000
148 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
149 SPEECH DISORDER 1 0.0000
150 HYPERTENSION 4 0.0000
151 HAEMATOCHEZIA 1 0.0000
152 PANCYTOPENIA 1 0.0000
153 FLATULENCE 1 0.0000
154 DYSPHONIA 1 0.0000
155 VERTIGO 1 0.0000
156 FEELING HOT 1 0.0000
157 AMNESIA 1 0.0000
158 PRODUCT DOSE OMISSION 1 0.0000
159 PSORIASIS 2 0.0000
160 COUGH 4 0.0000
161 INJURY 1 0.0000
162 THERAPY INTERRUPTED 1 0.0000
163 RESPIRATORY FAILURE 1 0.0000
164 UNEVALUABLE EVENT 1 0.0000
165 DECREASED APPETITE 3 0.0000
166 CARDIAC FAILURE CONGESTIVE 1 0.0000
167 THROMBOSIS 1 0.0000
168 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
169 DRY MOUTH 1 0.0000
170 RENAL IMPAIRMENT 1 0.0000
171 URINARY TRACT INFECTION 2 0.0000
172 MYOCARDIAL INFARCTION 2 0.0000
173 TACHYCARDIA 1 0.0000
174 SUICIDAL IDEATION 1 0.0000
175 CHEST PAIN 2 0.0000
176 CARDIAC DISORDER 1 0.0000
177 DYSPNOEA 6 0.0000
178 DYSPHAGIA 1 0.0000
179 PULMONARY EMBOLISM 1 0.0000
180 DYSPEPSIA 1 0.0000
181 SYNCOPE 1 0.0000
182 ABDOMINAL DISTENSION 1 0.0000
183 PNEUMONIA 3 0.0000
184 MALAISE 4 0.0000
185 INFLUENZA 1 0.0000
186 SEPSIS 1 0.0000
187 THROMBOCYTOPENIA 1 0.0000
188 MUSCULAR WEAKNESS 1 0.0000
189 PYREXIA 3 0.0000
190 CHILLS 1 0.0000
191 JOINT SWELLING 1 0.0000
192 EMOTIONAL DISTRESS 1 0.0000
193 VISUAL IMPAIRMENT 1 0.0000
194 HYPERHIDROSIS 1 0.0000
195 RENAL FAILURE 1 0.0000
196 VISION BLURRED 1 0.0000
197 ARTHRALGIA 3 0.0000
198 HOSPITALISATION 1 0.0000
199 HEADACHE 4 0.0000
200 PARAESTHESIA 1 0.0000
201 NAUSEA 5 0.0000
202 DIARRHOEA 4 0.0000
203 TREMOR 1 0.0000
204 ABDOMINAL DISCOMFORT 1 0.0000
205 TOXICITY TO VARIOUS AGENTS 1 0.0000
206 COVID-19 1 0.0000
207 NASOPHARYNGITIS 1 0.0000
208 HYPERSENSITIVITY 1 0.0000
209 PRODUCT USE ISSUE 1 0.0000
210 BLOOD GLUCOSE INCREASED 1 0.0000
211 ALOPECIA 1 0.0000
212 HYPOTENSION 1 0.0000
213 SOMNOLENCE 1 0.0000
214 PAIN 3 0.0000
215 ABDOMINAL PAIN UPPER 1 0.0000
216 WEIGHT INCREASED 1 0.0000
217 DEPRESSION 1 0.0000
218 BACK PAIN 1 0.0000
219 VOMITING 2 0.0000
220 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
221 DIZZINESS 2 0.0000
222 FATIGUE 3 0.0000
223 WEIGHT DECREASED 1 0.0000
224 ANXIETY 1 0.0000
225 DEATH 3 0.0000
226 PRODUCT DOSE OMISSION ISSUE 1 0.0000
227 PAIN IN EXTREMITY 1 0.0000
228 INJECTION SITE PAIN 1 0.0000
229 DRUG INEFFECTIVE 4 0.0000
230 FALL 1 0.0000
231 RASH 1 0.0000